Humanized non-opioid composition and therapies for pain management
AssigneesUNM Rainforest Innovations, Mayo Foundation for Medical Education and Research
InventorsKarin Westlund High, Adinarayana Kunamneni
Life of this patent
Estimating the term…
Abstract
A humanized anti-human P2X4R antibody, or an antigen binding fragment thereof, or a polypeptide, that inhibits human P2X4R activity, is provided as well as methods of making and using the antibody or an antigen binding fragment thereof.
Claims23
A composition comprising a humanized anti-human P2X4R antibody, or an antigen binding fragment thereof, or a polypeptide, that inhibits human P2X4R activity, wherein the antibody, the antigen binding fragment thereof, or the polypeptide has:
- i) a variable region comprising a first complementarity determining region (CDR) comprising GFTFTDYY (SEQ ID NO:1) operably linked to a second CDR comprising IRNKANGYTT (SEQ ID NO:2) operably linked to a third CDR comprising ARWEGDLLYAMDY (SEQ ID NO:3);
- and/or
- ii) a variable region comprising a first CDR comprising QGISNY (SEQ ID NO:4) operably linked to a second CDR comprising YTS operably linked to a third CDR comprising QQYSKLPWT (SEQ ID NO:6).
The composition of claim 2 wherein the antibody is a scFv.
An isolated cell comprising an expression cassette comprising a heterologous promoter operably linked to nucleic acid sequences encoding a humanized anti-human P2X4R antibody, or an antigen binding fragment thereof, or a polypeptide, that inhibits human P2X4R activity, wherein the antibody, the antigen binding fragment thereof, or the polypeptide has:
- i) a variable region comprising a first complementarity determining region (CDR) comprising GFTFTDYY (SEQ ID NO:1) operably linked to a second CDR comprising IRNKANGYTT (SEQ ID NO:2) operably linked to a third CDR comprising ARWEGDLLYAMDY (SEQ ID NO:3);
- and/or
- ii) a variable region comprising a first CDR comprising QGISNY (SEQ ID NO:4) operably linked to a second CDR comprising YTS operably linked to a third CDR comprising QQYSKLPWT (SEQ ID NO:6).
An isolated nucleic acid comprising a nucleotide sequence which encodes at least the variable region of a human heavy or light chain that binds human P2X4R, wherein the chain comprises:
- i) a variable region comprising a first complementarity determining region (CDR) comprising GFTFTDYY (SEQ ID NO:1) operably linked to a second CDR comprising IRNKANGYTT (SEQ ID NO:2) operably linked to a third CDR comprising ARWEGDLLYAMDY (SEQ ID NO:3);
- and/or
- ii) a variable region comprising a first CDR comprising QGISNY (SEQ ID NO:4) operably linked to a second CDR comprising YTS operably linked to a third CDR comprising QQYSKLPWT (SEQ ID NO:6).
A method to inhibit or treat depression, [or] anxiety or pain in a mammal, comprising:
- administering to a mammal a composition comprising an effective amount of a nucleotide sequence which encodes at least the variable region of a human heavy or light chain that binds human P2X4R, or an effective amount of an isolated polypeptide having at least the variable region of a human heavy or light chain that binds human P2X4R, wherein the chain comprises:
- i) a variable region comprising a first complementarity determining region (CDR) comprising GFTFTDYY (SEQ ID NO:1) operably linked to a second CDR comprising IRNKANGYTT (SEQ ID NO:2) operably linked to a third CDR comprising ARWEGDLLYAMDY (SEQ ID NO:3);
- and/or
- ii) a variable region comprising a first CDR comprising QGISNY (SEQ ID NO:4) operably linked to a second CDR comprising YTS operably linked to a third CDR comprising QQYSKLPWT (SEQ ID NO:6), or
- an antibody or fragment comprising
- i) a variable region comprising a first complementarity determining region (CDR) comprising GFTFTDYY (SEQ ID NO:1) operably linked to a second CDR comprising IRNKANGYTT (SEQ ID NO:2) operably linked to a third CDR comprising ARWEGDLLYAMDY (SEQ ID NO:3);
- and/or
- ii) a variable region comprising a first CDR comprising QGISNY (SEQ ID NO:4) operably linked to a second CDR comprising YTS operably linked to a third CDR comprising QQYSKLPWT (SEQ ID NO:6).
(canceled)
Dependencies are inferred from the claim text.